Smartlab Europe

Mannatech adds vitamin D to omega-3 supplement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Norgine Invests £23m to Expand Hengoed Pharma Facility in UK

Norgine has confirmed a £23 million ($31 million) investment...

Oral Microbiome Research and Its Implications for Future Therapeutics

Over the past decade, microbiome science has reshaped how...

Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal

Sanofi has committed up to $1.53 billion to obtain...
- Advertisement -

Mannatech, a developer and provider of nutritional supplements and skin care products based on Real Food Technology solutions, has added vitamin D to its omega-3 supplement. The new Omega-3 with Vitamin D3 capsules now comprise 830 IUs of vitamin D3 and continue to provide more than 1,000mg of concentrated EPA and DHA fatty acids.Mannatech’s decision to add vitamin D to its popular omega-3 supplement was prompted by expanding scientific research documenting the extensive health benefits of vitamin D.

Mannatech co-CEO and chief science officer Robert Sinnott said by adding vitamin D to their omega-3 supplement at no additional charge, they are making it easier for consumers to meet the recommended intake of the essential nutrients their bodies need but often don’t receive through a modern Western diet.

Latest stories

Related stories

Norgine Invests £23m to Expand Hengoed Pharma Facility in UK

Norgine has confirmed a £23 million ($31 million) investment...

Oral Microbiome Research and Its Implications for Future Therapeutics

Over the past decade, microbiome science has reshaped how...

Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal

Sanofi has committed up to $1.53 billion to obtain...

UK Invests £47.8M to Expand NHS Clinical Trial Capacity

The UK government has announced nearly £50 million in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »